First Review of ESMO’s Magnitude of Clinical Benefit Scale Offers a Thumbs-Up

First Review of ESMO’s Magnitude of Clinical Benefit Scale Offers a Thumbs-Up
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a valuable tool to measure the importance of clinically meaningful benefits that can be expected from a new anti-cancer drug in both common and rare diseases. Data from ESMO-MCBS on common tumors already had been obtained by researchers at Medical University of Vienna (MUV), one

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *